C ase report: A 54-year-old man is referred for dyspnea on exertion. He has a history of type II diabetes and 35 pack-years of smoking. He suffered an anterior myocardial infarction 14 months ago, and on recent echocardiography was found to have an ejection fraction of 25%. Since his myocardial infarction, he has quit smoking and has gained an additional 27 pounds. He admits to a sedentary lifestyle and has recently tried to initiate an exercise program in an effort to lose weight. His current body mass index is 33.4 kg/m 2 . He denies orthopnea but does have progressive lowerextremity edema.
What is the primary cause of his dyspnea? Is it ventilatory or circulatory? Obesity or deconditioning? What is the prognosis for his ischemic cardiomyopathy? What would be the appropriate diagnostic study to obtain these answers?
Background
Exercise stress testing is commonly used in clinical practice to evaluate the presence and severity of coronary ischemia. A significant enhancement of clinical information available during exercise can be obtained by concurrent measurement of respiratory gas exchange via use of a metabolic cart. This modality of stress testing has been called cardiopulmonary stress testing (CPX). This article will update the cardiovascular clinician on the utility of CPX in the modern cardiovascular practice.
A major function of the cardiovascular system is gas exchange, supplying O 2 and other fuels to working muscles, as well as removal of CO 2 and other metabolites. The heart, lungs, and pulmonary and systemic circulations form a single circuit for exchange of respiratory gases between the environment and the cells of the body. 1, 2 Under steady-state conditions, respiratory oxygen uptake (V O 2 ) and carbon dioxide outflow (V CO 2 ) measured at the mouth are equivalent to oxygen utilization (Q O 2 ) and carbon dioxide production (Q CO 2 ) occurring in the cell, thus "external respiration" equals "internal respiration." CPX directly measures V O 2 , V CO 2 , and air flow (minute ventilation [V E], tidal volume, and respiratory rate) on a breath-by-breath basis using a nonrebreathing valve connected to a metabolic cart. Samples of expired air are typically assessed every 15 seconds, and real-time data are expressed in both a tabular and graphic format. Additionally, oxygen saturation using finger or ear oximetry is monitored and recorded. From these data, numerous clinically relevant metabolic parameters can be derived ( Table 1) . The abbreviations used subsequently are explained in Table 1 .
Metabolic Derangements in Disease
Metabolic derangements can occur at multiple sites within the circuitry of gas exchange, including the consumers at the muscle mitochondria, the transporters within the circulatory system, to the exchangers at the site of ventilation ( Figure 1 ). Knowledge of site and extent of metabolic dysfunction can have a wide application in clinical medicine ( Table 2) . CPX provides an ideal modality for the evaluation of patients presenting with exertional dyspnea and fatigue, at which time the clinician is faced with a breadth of differential diagnoses ranging from circulatory impairment to deconditioning. Standard diagnostic studies may not identify the true cause because circulatory and ventilatory reserves cannot be assessed from indices of resting cardiac and pulmonary function. 3 By virtue of obtaining gas exchange data under the provocation of exercise, CPX can discriminate among many subtle and often overlapping etiologies.
Etiology of Dyspnea
Using the algorithm provided in Figure  2 , a peak oxygen uptake (PkV O 2 ) Ͻ85% of that predicted by age and gender is considered to be low, and a normal anaerobic threshold (AT) is generally closer to 60% of the predicted PkV O 2 . For purposes of classification, an AT Ͻ40% of the predicted peak V O 2 is considered pathologically reduced and indicative of circulatory insufficiency. A breathing reserve (BR) Ͻ30% would indicate ventilatory impairment, especially when accompanied by oxygen desaturation with exercise, although a BR of 20% to 30% is deemed a borderline value. CPX is very useful in dyspneic patients with combined cardiac and pulmonary diseases who may have a reduction in both AT and BR, the more dominant of which may indicate the primary cause of the patient's functional limitation. A respiratory exchange ratio (RER) of Ͻ1.1 (particularly Ͻ1.0) in the absence of other metabolic abnormalities suggests poor effort, anxiety, or mild disease. Finally, this type of evaluation can be helpful in patients being evaluated for employment disability.
Heart Failure Prognosis
From a clinical standpoint, probably the greatest utilization of CPX has been in the evaluation of patients with advanced systolic heart failure, in which CPX has gained widespread use by virtue of its superior prognostic capabilities in these patients. In the Veterans Administration Heart Failure Trial (V-HeFT), the mortality rate of patients with a V O 2 max Յ14.5 mL/kg per minute was double that of patients whose V O 2 max exceeded this value, a finding more significant than the drug treatment effect being studied. 4 In a separate investigation of heart failure patients referred for cardiac transplantation, Mancini et al 5 found that PkV O 2 was the single best predictor of survival. Moreover, transplantation could be safely deferred in patients whose PkV O 2 was Ͼ14 mL/kg per minute, where their survival exceeded that of patients undergoing heart transplantation. As a result of these seminal studies, CPX remains a pivotal modality in initial evaluation of patients with advanced heart failure, especially those who are considered for heart transplantation. The commonly used Weber-Janicki classification of exercise capacity in heart failure is provided in Table 3 . 6 Although a PkV O 2 cutoff of 14 mL/kg per minute remains an important prognostic discriminator in heart failure patients, our laboratory and others have described disparities in its • Maximal oxygen uptake (V O 2 max): The value achieved when V O 2 remains stable despite a progressive increase in the intensity of exercise. This is synonymous with peak aerobic capacity.
• Breathing reserve (BR): The reserve capacity of the ventilatory system, calculated as 1 minus the ratio of peak exercise minute ventilation (V E) to maximal voluntary ventilation. A normal value would be Ն30%.
• Anaerobic threshold (AT): The highest oxygen uptake attained without a sustained increase in blood lactate concentration and lactate/pyruvate ratio. Reported as a weight-adjusted parameter in mL/kg per minute.
• Respiratory exchange ratio (RER): Related but not equivalent to its cellular counterpart, the respiratory quotient, and is defined as the ratio of V CO 2 to V O 2 .
• Oxygen saturation (SpO 2 ): The percentage of hemoglobin that is saturated with oxygen. Typically measured by pulse oximetry.
• O 2 pulse: The amount of O 2 consumed from the volume of blood delivered to tissues by each heartbeat; is calculated as: O 2 pulseϭV O 2 /heart rate.
• Ventilation/carbon dioxide production ratio (V E/V CO 2 ): Also known as the ventilatory equivalent for CO 2 , this represents a respiratory control function that reflects chemoreceptor sensitivity, acid-base balance, and ventilatory efficiency.
• Peak V O 2 lean: The peak oxygen uptake adjusted for lean body mass. Reported as a lean body weight-adjusted parameter in mL/kg per minute. prognostic utility when evaluating patients with intermediate levels of PkV O 2 (between 10 and 18 mL/kg per minute) as well as in special populations such as women and obese patients. [7] [8] [9] Investigators have therefore sought to evaluate the predictive strength of other metabolic parameters in advanced heart failure, including percent predicted PkV O 2 , 10 ventilation/ carbon dioxide production ratio and slope, 11 oxygen consumption recovery, 12 and O 2 pulse. 13, 14 Each investigation demonstrated variability with regard to each parameter's predictive strength. Moreover, a recent investigation suggests that the widespread use of ␤-blocker therapy in heart failure may require alteration of the PkV O 2 cutoff point of 14 mL/kg per minute to a lower value. 15 A fundamental understanding of O 2 consumption may explain the disparate observations in women and obese patients. Although PkV O 2 is corrected for total body weight, body fat is "metabolically inert," consuming essentially no oxygen, and can represent a significant portion of total weight. Moreover, considerable variability in body composition is present across populations, including those with heart failure. We demonstrated that correcting PkV O 2 for lean body mass (PkV O 2 lean) provides a more refined discriminator of outcome than traditionally reported total weight-adjusted values. 16 In heart failure patients, a PkV O 2 lean cutoff of 19 mL/kg per minute provides a more robust discriminator than the total weight-adjusted figure of 14 mL/kg per minute. As such, we routinely assess body fat using the 3-site skinfold method before each CPX study to calculate lean body mass. 17 From a practical standpoint, this adds only 3 to 4 minutes to the time required to perform a CPX. Using the lean adjusted peak oxygen uptake, we eliminated previously observed disparities between genders, and between obese and nonobese patients, in predicting outcome in heart failure. We also reported the usefulness of peak O 2 pulse (cutoff value 10 mL/beat), especially when corrected for lean body mass (cutoff value 14 mL/beat), in predicting prognosis in patients with chronic systolic heart failure. 18 Less commonly, clinicians need to evaluate heart failure patients who have very limited exercise tolerance resulting from low threshold angina or severe ventricular arrhythmias, in which an early exercise surrogate of PkV O 2 would be required for risk stratification. Our laboratory and others successfully used the pattern of V E/ V CO 2 change during early exercise to predict PkV O 2 and subsequent outcome in such patients. 11, 19, 20 We found that a decrease in V E/V CO 2 of Ͻ10% early in exercise predicts a PkV O 2 of Ͻ14 mL/kg per minute and poor outcome in patients with heart failure.
Pitfalls in CPX Interpretation
In general, data obtained from CPX are reliable and reproducible, but as with any clinical modality, there may be pitfalls in collecting and interpreting metabolic data obtained during exercise. Among the most important requirements in performing CPX is a skilled technician who provides thorough instruction to patients before testing, as well as encouragement during exercise. The technician must be meticulous in monitoring data as they are acquired and be cognizant of system leaks (breathing around mouthpiece, nasal breathing, or sampling line leaks) in data acquisition. V O 2 is now a commonly used end point in various clinical investigations, particularly heart failure trials. [21] [22] [23] Changes in PkV O 2 , therefore, may have important prognostic and therapeutic consequences. 24, 25 An increase in PkV O 2 by as little as 1 mL/kg per minute can mean as much as a 69second gain in treadmill exercise time, as well as improved cardiovascular outcomes. 24, 26 In this context, however, it is important to remember that several factors, including effort, can influence the PkV O 2 value. Consequently, PkV O 2 may not always be the appropriate metabolic end point to evaluate the effects of a given intervention (Figure 3 ). Because PkV O 2 can be effort dependent, Pina and Karalis 27 demonstrated that AT rather than PkV O 2 was a more reproducible and effort-independent parameter in heart 28 In the less common event that AT is not achieved, an occurrence in up to 30% of our heart failure population, we successfully used the pattern of V E/V CO 2 change in early exercise to predict PkV O 2 and subsequent outcomes in such patients. 11, 19, 20 
Conclusions
Returning to our case study, the patient exercised for 9 minutes on an intermediate ramping protocol, stopping secondary to shortness of breath, achieving a peak heart rate of 149 bpm (90% of predicted). There were no electrocardiographic changes suggestive of ischemia. The principal metabolic data were as follows: On the basis of the interpretative schema in Figure 2 , we conclude that this patient demonstrated an adequate effort (RER Ն1.1) with a low peak aerobic capacity (PkV O 2 63% of predicted). The AT was normal, suggesting adequate circulatory status. Additionally, the BR and O 2 saturation at peak exercise were in the normal range, thereby excluding a ventilatory etiology to the patient's symptoms. Despite the underlying presence of a cardiomyopathy, the most likely explanation for the patient's symptoms is deconditioning, in large part due to the patient's obesity. The cardiopulmonary data suggest a very favorable prognosis for his cardiomyopathy. The patient's symptoms can be improved and possibly eliminated by enrollment into a structured conditioning program of exercise training. 
